colorectal cancer

The FDA has accepted for review Amneal Pharmaceuticals Inc's (NYSE: AMRX) marketing application seeking approval for Bevacizumab, under Section 351(k) pathway of the Public Health Service Act. The covers for the treatment of metastatic colorectal cancer, in combination with IV...

The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Bristol Myers Squibb & Co's (NYSE: BMY) Opdivo (nivolumab) in combination with Yervoy (ipilimumab), a subset of metastatic colorectal cancer (mCRC). The...

Cardiff Oncology Inc (NASDAQ: CRDF) has announced data from its ongoing Phase 1b/2 trial evaluating onvansertib combined with standard-of-care therapy in second-line KRAS-mutated metastatic colorectal cancer (mCRC). Patients enrolled in the trial receive onvansertib combined...

Humana Inc (NYSE: HUM) has finally come around after showing intransigence in including EXACT Sciences Corporation (NASDAQ: EXAS)'s Cologuard test in its coverage policy. Humana's Commentary A Humana spokesperson told Benzinga exclusively that starting January 1, 2017, "Humana's Commercial members...

Uncomfortable and invasive colonoscopies might be a thing of the past with VolitionRX Ltd's (NYSE: VNRX) new cancer detection system. Through its research, VolitionRX developed a method for testing blood samples to detect various types of cancer, making diagnosis more accurate and reliable...